RACK1 overexpression associates with pancreatic ductal adenocarcinoma growth and poor prognosis

Xiaohong Li; Ying Xiao; Shaoqing Fan; Mingbing Xiao; Xiaotong Wang; Xudong Chen; Chunsun Li; Guijuan Zong; Guoxiong Zhou; Chunhua Wan

doi:10.1016/j.yexmp.2016.08.001

JOURNAL ARTICLE

RACK1 overexpression associates with pancreatic ductal adenocarcinoma growth and poor prognosis

Xiaohong Li Ying Xiao Shaoqing Fan Mingbing Xiao Xiaotong Wang Xudong Chen Chunsun Li Guijuan Zong Guoxiong Zhou Chunhua Wan

Year: 2016 Journal: Experimental and Molecular Pathology Vol: 101 (2)Pages: 176-186 Publisher: Elsevier BV

DOI: 10.1016/j.yexmp.2016.08.001

Get Full-Text PDF Get Analytical Report

Keywords:

Cell cycle Cancer research Biology Downregulation and upregulation Western blot Apoptosis Cell growth Pancreatic cancer Flow cytometry Cyclin D1 Gene silencing Annexin Cancer Molecular biology

Metrics

Cited By

0.83

FWCI (Field Weighted Citation Impact)

Refs

0.76

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

Pancreatic and Hepatic Oncology Research

Health Sciences → Medicine → Oncology

Pancreatitis Pathology and Treatment

Health Sciences → Medicine → Surgery

TGF-β signaling in diseases

Life Sciences → Biochemistry, Genetics and Molecular Biology → Molecular Biology

RACK1 overexpression associates with pancreatic ductal adenocarcinoma growth and poor prognosis

Metrics

Citation History

Topics

Related Documents

DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma

High expression of RACK1 is associated with poor prognosis in patients with pancreatic ductal adenocarcinoma

Overexpression of MYEOV predicting poor prognosis in patients with pancreatic ductal adenocarcinoma

KIAA1199/CEMIP/HYBID overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma

Fibroblast growth factor 8 overexpression is predictive of poor prognosis in pancreatic ductal adenocarcinoma